⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole Acetic Acid SCHEMBL8482521 | 0.98 | ALDH1A1 (1.00) | — | |
| Imidazole Acetic Acid SCHEMBL15260951 | 0.96 | ALDH1A1 (0.92) | — | |
| SCHEMBL8818280 | 0.84 | CYP3A4 (0.73) | — | |
| SCHEMBL1331769 | 0.83 | ALDH1A1 (0.71) | — | |
| Methyl Alcohol SCHEMBL11465646 | 0.81 | ALDH1A1 (0.68) | — | |
| SCHEMBL686528 | 0.81 | — | — | |
| SCHEMBL34468467 | 0.81 | — | — | |
| SCHEMBL890227 | 0.81 | — | — | |
| SCHEMBL11465647 | 0.79 | CYP3A4 (0.66) | — | |
| SCHEMBL1527998 | 0.79 | TBXAS1 (0.72) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9453 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070165-A | Fusion proteins for affinity capture | 思拓凡生物工艺研发有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122042790-A | Serum protein marker combination for glioma diagnosis and prognosis evaluation and diagnosis system thereof | 元通汇泽(陕西)生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026099598-A1 | A DIAGNOSTIC METHOD | UNIVERSITY OF LEICESTER (GB) | 2026-05-15 | — | — | WO | claimed |
| EP-4397977-B1 | SYSTEMS AND METHODS FOR PREPARING A SAMPLE AND PERFORMING A REAL-TIME ASSAY OF THE SAMPLE | AMGEN INC (US) | 2026-04-29 | — | — | EP | claimed |
| US-12575729-B2 | Bimodal method for detection and measurement of macular pigments in retina tissue | OcuScore, LLC (US) | 2026-03-17 | — | — | US | claimed |
| EP-4705451-A1 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | Lonza Sales AG (CH) | 2026-03-11 | — | — | EP | claimed |
| EP-3256576-B1 | MIXTURE OF PURIFIED SODS OF PLANT ORIGIN | BIONOV (FR) | 2026-01-28 | — | — | EP | claimed |
| EP-4667931-A2 | PROTEOFORM SPECIFIC PROCESS VALIDATION | Novilytic, LLC (US) | 2025-12-24 | — | — | EP | claimed |
| EP-3865143-B1 | PREPARATION OF FETUIN A | PREVIPHARMA GMBH (DE) | 2025-12-24 | — | — | EP | claimed |
| US-20250354997-A1 | Proteoform Specific Process Validation | NOVILYTIC LLC (US) | 2025-11-20 | — | — | US | claimed |
| EP-3948283-A1 | A METHOD FOR SEPARATING BIOMOLECULES | Cytiva Sweden AB (SE) | 2022-02-09 | — | — | EP | claimed |
| CN-110096307-B | Communication processor | 北京思朗科技有限责任公司 | 2022-02-01 | — | — | CN | claimed |
| EP-3796976-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO THE QUALITY OF AGING AND LONGEVITY | Epitracker, Inc. (US) | 2021-03-31 | — | — | EP | claimed |
| US-8492344-B2 | PDK inhibitor compounds and methods of use thereof | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2013-07-23 | — | — | US | claimed |
| WO-2013024028-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING PROTEINOPATHIES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2013-02-21 | — | — | WO | claimed |
| CN-101341131-A | Imidazoles as gaba-b receptor modulators | ASTRAZENECA AB (SE) | 2009-01-07 | — | — | CN | claimed |
| US-20080312305-A1 | Imidazoles as Gaba- B Receptor Modulators | ASTRAZENECA AB (SE) | 2008-12-18 | — | — | US | claimed |
| EP-1968946-A1 | IMIDAZOLES AS GABA-B RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2008-09-17 | — | — | EP | claimed |
| WO-2007073299-A1 | IMIDAZOLES AS GABA-B RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2007-06-28 | — | — | WO | claimed |
| EP-1233015-A1 | Use of imidazole derivatives for the treatement of deseases involving the AT1 and AT2s receptors of angiotensine, some of these products, their preparation, their application as medicaments and pharmaceutical compositions containing them | Aventis Pharma S.A. (FR) | 2002-08-21 | — | — | EP | claimed |